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Abstract
We revisit the topic of human genome guanine-cytosine content under neutral evolution.
For this study, the de novo mutation data within human is used to estimate mutational rate
instead of using base substitution data between related species. We then define a new measure
of mutation bias which separate the de novo mutation counts from the background guanine-
cytosine content itself, making comparison between different datasets easier. We derive a new
formula for calculating limiting guanine-cytosine content by separating CpG-involved muta-
tional events as an independent variable. Using the formula when CpG-involved mutations are
considered, the guanine-cytosine content drops less severely in the limit of neutral dynamics.
We provide evidence, under certain assumptions, that an isochore-like structure might remain
as a limiting configuration of the neutral mutational dynamics.
keywords: de novo mutation, human genome, neutral evolution, limiting G+C
content, CpG dinucleotide
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Introduction
It is well known that in genomes of many species from fish (Costantini et al., 2007) to human
(Bernardi, 1989; Costantini et al., 2006), there is an alternation of DNA segments with high
and low guanine-plus-cytosine (G+C) content, called isochores (Bernardi, 1985, 2006). Such
change between high and low G+C content leads to a higher variance with respect to DNA
walk properties than expected from a simple homogeneous stochastic model (Fickett et al.,
1992) – thus the term heterogeneity has been adopted (Sueoka, 1962; Li et al., 1998). The
physical spatial arrangement of G+C content in genomes can be more complicated. Com-
monly observed examples of the spatial complexity are the variable length of these isochores,
the isochore-within-isochore phenomenon, and a slower than exponential decay of base-to-
base autocorrelation function, called long-range correlation (Li and Kaneko, 1992; Peng et al.,
1992). An isochore is not simply a statistical signal: it has functional information also. The
richest isochores tend to be gene rich (Zerial et al., 1986), and genes tend to have higher G+C
content (Clay et al., 1996). G+C content may also be associated with inner/outer region of
a chromatin structure (Jabbari and Bernardi, 2017), though the cause-effect relationship be-
tween the two is not completely clear (Li, 2013). G+C content of genomes of more than one
thousand species is presently known (Wang, 2018).
Based on the synonymous substitution rates in protein coding regions obtained from differ-
ent mammalian species, it was concluded that because G/C → A/T substitution rate (from
ancestral outgroup to descendant ingroup) is higher than the A/T → G/C rate, all genomic
regions will move towards a lower equilibrium G+C content (Duret et al., 2002; Belle et al.,
2004), though counter evidence was also presented (Alvarez-Valin et al., 2004; Gu and Li, 2006;
Romiguier et al., 2010). These data from different diverging species contain information from
a very long time scale, and mix various factors from mutation rates to selection.
Another observation is that the G/C→ A/T to A/T→G/C substitution rate ratio is a func-
tion of the G+C content, based on the substitutions in DNA transposons, a type of repetitive
sequences (International Human Genome Sequencing Consortium, 2001). This result is not
inconsistent with (Duret et al., 2002), where the absolute counts of G/C→ A/T substitutions
over the A/T→ G/C substitution counts, increases with G+C content. However, there is a dif-
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ference between the two approaches: the ratio in (International Human Genome Sequencing Consortium,
2001) is based on conditional probability (conditional on G+C content), whereas the ratio in
(Duret et al., 2002) is unconditional. This discrepancy is not usually emphasized, which can
cause confusion when different results are compared.
If we want to disentangle different causes, and only focus on the consequence of short-time-
scale point mutations, it would be ideal to catch mutational events in “real time”. Fortunately,
in the genetic study of human diseases, the “de novo” mutation – genetic variant absent in
parents’ genome but present in offspring’s genome – has been extensively investigated in both
diseased and normal samples (Kong et al., 2012; Francioli et al., 2015). The data becomes
more important as there is evidence that de novo mutations might play a role in many hu-
man diseases, such autism spectrum disorders (Sebat et al., 2007), schizophrenia (Girard et al.,
2011), intellectual disability (Vessers et al., 2010; Hamdan et al., 2014), developmental disor-
ders (Deciphering Developmental Disorders Study, 2018), and others (Veltman and Brunner,
2012; Samocha et al., 2014).
There are several distinct features of de novomutation data compared to the substitutions in
mammalian species: (1) a mutation occurs within one species, the Homo sapiens, not mutations
leading to base differences between species (i.e. substitution); (2) a mutation occurs in the
current time, and we do not deal with ancestral mutational events in the past, which were
likely to be different as it was from a potentially different environment; (3) for a normal,
disease-free offspring, a de novo mutation is unlikely to be deleterious, thus the requirement
of neutral evolution is satisfied. We also do not need to assume the spread as well as fixation
of a mutational allele when substitutions between species are used; (4) a mutation is more
directly observed, by comparing parents’ and offspring’s genome, not by comparing the inferred
ancestral genome with the descendant genomes; (5) due to availability of the human reference
genome, not only a whole genome data can be readily obtained, but also the genomic context of
a mutation location is well annotated, unlike the situation of many other mammalian genomes.
The large number of de novo studies in the human genome in the recent years (Pranckeniene et al.,
2018; Jonsson et al., 2018; Goldmann, 2018; Wang et al., 2019; Kessler et al., 2020) may make
the data collection daunting. Fortunately, there exist de novo databases which we can use
directly. Note that, unlike most people who are more interested in functional de novo muta-
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tions that cause genetic diseases, here we are interested in the neutral de novo mutations in
the general population.
The study is organized as follows: we first focus on the theoretical framework relating de
novo mutation rate and G+C content. We re-derive the formula of the limiting G+C content
in single-base-mutation-driven neutral dynamics in terms of mutation counts between strong
and weak bases. We define coefficients α1, α2 based on mutation counts (not on mutation
rate), and their deviation from the value of 1/2 immediately reveals which type of base will
increase/decrease in the limiting dynamics. We then expand our formula to dynamics of
three variables (weak bases, strong bases not-involved in CpG dinucleotides, and strong bases
involved in CpG dinucleotide). We define coefficients β1, β2, β3 based on mutation counts
among these three variables, and a deviation of their value from 1/3 immediately predicts the
limiting dynamics of them. We carry out a data analysis using the de novo mutation database
to estimate α’s and β’s in different location types, as well as in different G+C backgrounds.
Theoretical formulation
Formula of limiting G+C content based on mutation-driven neutral dynamics
Assume that a certain number (= nWS) of weak (A or T) to strong (C or G) de novo
mutation events is observed, and similarly there are nSW strong-to-weak mutation events.
Denote the G+C-content as x; assume that there are N genomic positions to be considered,
and M is the number of persons from which de novo mutation events were collected, then
there are M ·N · x positions occupied by strong bases, and M ·N · (1− x) positions by weak
bases. We then compose the mutation (and non-mutation) event counts matrix as:
W = A/T S = C/G
W = A/T
S = C/G

 MN(1 − x)− nWS nWS
nSW MNx − nSW

 (1)
The diagonal elements in Eq.(1) are mostly not directly counted, simply because (e.g.) A→ A
is not reported as a mutation event (though (e.g.) A → T is). However, we can infer them
from the total number of base positions N , total number of samples M , the current G+C
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content x, and the mutation counts away from the base type.
Normalizing the matrix in Eq.(1) by row sum, we obtain the conditional probability (tran-
sition probability in Markov chain):
W = A/T S = C/G
W = A/T
S = C/G

 1− nWSMN(1−x) pW→S ≡ nWSMN(1−x)
pS→W ≡
nSW
MNx
1− nSW
MNx

 (2)
From the two weak ↔ strong (conditional) transition probabilities, it is well known that the
limiting G+C (strong) content is (Sueoka, 1962; Petrov and Hartle, 1999; Lynch, 2007, 2010;
International Human Genome Sequencing Consortium, 2001; Li, 2011, 2013):
x′ =
1
pS→W
pW→S
+ 1
. (3)
An easy derivation is to consider the “detailed balance”: x′pS→W = (1− x
′)pW→S.
We define two new coefficients based on the mutational event counts: α1 = nSW/(nSW +
nWS) and α2 = nWS/(nSW + nWS). Note
∑
i αi = 1. The conditional transition probability in
Eq.(3) can be replaced by the de novo mutational event counts (nSW and nWS) or α’s:
x′ =
1
nSW
nWS
· 1−x
x
+ 1
. =
1
α1(x)
α2(x)
· 1−x
x
+ 1
. (4)
Both total number of bases N and number of persons M are canceled from Eq.(4), thus we do
not need to know their values. Eq.(4) shows how the limiting G+C content (x’) depends on
the current G+C content (x), and two (actually one) mutational count based coefficients α1
(α2 = 1− α1). Eq.(4) can be written in a more symmetric form:
x′
1− x′
=
nWS
nSW
·
(
x
1− x
)
=
α2(x)
α1(x)
·
(
x
1− x
)
. (5)
As long as nWS < nSW (or α2 < α1, more C/G to C/T mutation events than in the opposite
direction), x/(1− x) will decrease, so will G+C-content x.
Note that Eq.(5) is not a one-time iteration, from time t to time t + 1, typically seen in
the field of dynamical systems (May, 1976; Li and Yorke, 1975; Feigenbaum, 1978). Eq.(5)
maps directly from the current G+C-content to the limiting G+C-content in one step. The
base transition counts (nSW and nWS) or their normalized values (α1 and α2) are not constant
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values, but changing as a function of the current G+C-content. If G+C-content reduces,
we should also see a lower value of α1. To emphasize this point, we write this functional
dependence of α1 and α2 on x in Eqs.(4,5) explicitly.
In the literature, the mutational bias towards W=A+T is defined as m = pS→W/pW→S =
v/u (Lynch, 2007) (page-126), or the equilibrium constant in the direction of W base pairs K
(International Human Genome Sequencing Consortium, 2001) (page-886), whereas their de-
pendence on G+C-content is not obvious. In our notation, K = [α1(x)/α2(x)] · [(1 − x)/x] is
expressed in two parts so that it is made explicit that the first part is derived purely from the
mutation counts α1/α1 = nSW/nWS and the second part is unrelated to mutation counts, but
purely base composition related.
There is another advantage of using α1,2 instead of the mutational bias K. When the values
of α1,2 are compared to 0.5, we immediately know the direction of the base type change: if
α1 > 0.5, (A+T)-content will increase from the current value to its limiting value; similarly if
α2 > 0.5, (G+C)-content will increase. This advantage is more clear in the next subsection
when three variables are considered.
Formula of limiting G+C content when CpG is considered separately
Now we specifically consider a subset of strong bases within the 5’-CpG-3’ dinucleotide
context. The base C next to a base G in downstream (3’) direction is known to have a much
higher mutation rate (in particularly, to base T). The dinucleotide on the opposite strand
of 5’-CpG-3’ is also 5’-CpG-3’, but the base G is expected to have a higher mutation rate.
Let’s denote these strong bases as Sp (p indicates the phosphodiester bond between C and G)
and other G/C bases not in this context as Sn. We also assume among strong G/C bases, a
proportion of y of them are in Sp. Though not common, it is still possible to have a mutation
from one Sp base to another Sp base, e.g., 5
′ − CGG− 3′ → 5′ − CCG− 3′.
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Similar to Eq.(1), the number of mutation counts for three types of base (W, Sn, Sp) are:
W Sn Sp
W
Sn
Sp


MN(1 − x)− nWSn − nWSp nWSn nWSp
nSnW MNx(1 − y)− nSnW − nSnSp nSnSp
nSpW nSpSn MNxy − nSpW − nSpSn


and again, the row normalized matrix is the transition matrix:
W Sn Sp
W
Sn
Sp


1−
nWSn+nWSp
MN(1−x)
nWSn
MN(1−x)
nWSp
MN(1−x)
nSnW
MNx(1−y)
1−
nSnW+nSnSp
MNx(1−y)
nSnSp
MNx(1−y)
nSpW
MNxy
nSpSn
MNxy
1−
nSpW+nSpSn
MNxy


(6)
The limiting composition ofW,Sn, Sp is proportion to the eigenvector of the transpose (switch-
ing rows and columns) of Eq.(6) corresponding to the eigenvalue equal to 1 (which is the largest
eigenvalue of a Markov transition matrix) (see Appendix). We obtain such a (unnormalized)
eigenvector for the transpose of Eq.(6) by Wolfram Alpha (www.wolframalpha.com) as:

(nSpWnSnW + nSnSpnSpW + nSpSnnSnW )(1− x)
(nWSnnSpSn + nWSpnSpSn + nSpWnWSn)x(1− y)
(nWSpnSnSp + nWSnnSnSp + nSnWnWSp)xy

 ∝


β1(x) · (1− x)
β2(x) · x(1− y)
β3(x) · xy

 . (7)
Although Eq.(7) looks complicated, it can be memorized by the illustration in Fig.1. Note that
again the genome size N and number of persons M are not present in the limiting composition
formula Eq.(7).
We introduce new coefficients βi (i=1,2,3) to be proportional to the coefficients in the
left column-array in Eq.(7), but normalized (i.e., divided by the sum of all products of two
transition counts). Note that
∑
i βi = 1 doesn’t mean the right column array itself in Eq.(7) is
normalized. Our introduction of βi coefficients will make the comparison between different data
easier, because they are based purely on mutational counts. Also, if β1 = β2 = β3 = 1/3 implies
no change in the composition of weak, CpG-unrelated-strong, and CpG-related-strong base
types, and deviation of β from 1/3 easily points to the direction of change in the composition.
To emphasize the fact that {βi} are not constant in the dynamics, we write their dependence
on G+C-content explicitly in Eq.(7).
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Data analyses
Filtering neutral de novo mutation events
We use the denovo-db v1.6.1 (http://denovo-db.gs.washington.edu/denovo-db/, August 19,
2018). The files denovo-db.ssc-samples.variants.tsv and denovo-db.non-ssc-samples.variants.tsv
are used. Each line in these files is a mutational event in a person with a particular annotation.
Therefore, for a mutation in a coding region with multiple transcripts, each mutation event
may occupy multiple lines. There are 628,234 lines in the two files. The genomic coordinates
are in hg19/GRCh37.
We filter the de novo mutations by the following criteria: (1) The mutation is a bi-allelic
single-nucleotide-polymorphism (SNP); (2) The person’s phenotype is a normal “control”; (3)
Y-chromosome variants are excluded; (4) the base is consistent with the reference genome of
hg19/GRCh37. The criterion #1 serves to avoid the more complicated mutational events such
as indels and multi-allelic variants whose detection is less reliable. The criteria #2 is to make
sure that the mutational event is neutral, and less likely to be deleterious. These filterings
reduce the number of lines to 110,989.
The following studies have contributed the most to the de novo mutation event counts:
Turner2017 (83187, 75.0%) (Turner et al., 2017), GONL (15896, 14.3%) (Genome of the Netherlands Consortium,
2014), Turner2016 (3541, 3.2%) (Turner et al., 2016), Iossifov2014 (3521, 3.2% ) (Iossifov et al.,
2014), Werling2018 (3302, 3.0% ) (Werling et al., 2018), Krumm (1014, 0.9%) (Krumm et al.,
2015), Yuen2017 (181, 0.16%) (Yuen et al., 2017), Gulsuner2013 (170, 0.15%) (Gulsuner et al.,
2013), Conrad2011 (59, 0.05%) (Conrad et al., 2011), Besenbacher2014 (52, 0.047%) (Besenbacher et al.,
2015), Rauch2012 (509, 0.045%) (Rauch et al., 2012), and ASD3 (15, 0.014%).
Besides the information provided by denovo-db, we have added these extra information
by using the hg19/GRCh37 reference genome: (1) G+C base and CpG dinucleotide count of
2kb window centered at the SNP; (2) G+C base and CpG dinucleotide count of 20kb window
centered at the SNP; (3) the triplet context of the SNP; and (4) the triplet context after the
mutation.
The denovo-db provides 18 location-types which we condense to 9 types: intron (and intron-
near-splice): 58824 lines, intergenic: 40375 lines, upstream-gene and downstream-gene: 4832
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lines, missense(and missense-near-splice): 3235 lines, 5’ and 3’ UTR: 1514 lines, synonymous
(and synonymous-nea-splice): 1336 lines, non-coding-exon (and non-coding-exon-near-splice):
634 lines, stop-lost and stop-gain: 149 lines, splice-acceptor and splice-donor: 81 lines.
Fig.2 shows the distribution of CADD (combined annotation dependent depletion) value
(Kircher et al., 2014), percentage of non-repetitive-sequence (uppercase letter), 2kb window
G+C content, 20kb window G+C content, 2kb widow CpG%/(G+C)%, and 20kb widow
CpG%/(G+C)% of all these 9 location types. Most of the result in Fig.2 is known. For exam-
ple, the functional impact of variants is the highest for stop-gain/lost, followed by missense;
intergenic regions contain more repetitive sequences or transposons; genic regions can be of
high-(G+C)-content; etc. We further show that larger window (20kb) statistics have more
narrow distributions, and intron regions (even more so than intergenic regions) avoid CpG
dinucleotides.
De novo mutation derived α and β coefficients
Table 1 shows the raw count of different types of de novo mutations in 9 different variant
types described in the last section. The two α1 and α2 coefficients for the two-base type model
and three β1, β2, β3 coefficients for the three-base type model are listed in Table 1. Although
we cannot assume neutral dynamics for variants in the functional categories, whether an αi
coefficient larger or smaller than 1/2, and whether a βi coefficient larger or smaller than 1/3
will indicate which direction the mutational force is pushing. In all functional categories, W
(A+T) base content will be pushed higher by mutation, S(G+C) and CpG content will be
pushed lower. The stop-gain/loss and splice acceptor/donor categories contain very few de
novo mutation counts. However, the mutational force would drive the CpG content higher in
splice sites, while deplete CpG from stop sites.
Bases in the intergenic regions can be assumed to follow a neutral evolution without con-
straints. We further partition the de novo mutational events in intergenic regions according
to its surrounding (2kb) (G+C)-content, and α, β coefficients are calculated in each (G+C)-
content quantile. The results are shown in Table 2. We can see that not only α1 > 1/2 and β1 >
1/3, but also their values increase with the surrounding G+C content. This result is consistent
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with previous publications (Duret et al., 2002; International Human Genome Sequencing Consortium,
2001). Table 2 also shows that β3 < 1/3, and decreases with surrounding G+C content.
Dependence of CpG mutation rate on local G+C content has also been reported before
(Fryxell and Moon, 2005).
Evidence of two different limiting G+C contents
To further examine the prediction of our neutral mutational dynamics, using the mutation
rates based on the de novo mutational event count, as a function of current G+C content,
we expand the previous six G+C content quantiles to eight, with the highest G+C range
split into three more G+C regions. This partition would lead to around 6000-7000 intergenic
de novo mutational events in each one of the lower G+C brackets, but 2000-3000 intergenic
mutational events in the last three high G+C brackets. The mutation counts of various types,
the calculated α(x)’s and β(x)’s, the predicted limiting G+C content (by either two-variable
or three-variable equation) and limiting CpG/(G+C), are shown in Table 2. The current
intergenic G+C content and CpG/(G+C) values, calculated directly from the hg19 intergenic
sequences (an intergenic sequence longer than 10kb is partitioned into pieces of 10kb length),
are shown in Fig.3. We notice that CpG/(G+C) is positively correlated with (G+C) %, as it
involves the product of two strong bases.
Fig.4 depicts the mutational data as a function of current (G+C)% from various perspec-
tives. Fig.4(A) shows that the p(S → W )/p(S → W ) is not constant, but decreases at high
(G+C) content. By the prediction in Eq.(3), the limiting (G+C)% will be higher for the
current (G+C)-rich intergenic regions, as shown in Fig.4(B). Interestingly, the three-variable
prediction (by considering CpG-containing strong base as a distinct variable) leads to slightly
higher limiting (G+C)% than the two-variable prediction. Fig.4(C), however, shows that the
limiting CpG/(G+C) may not be off very much from the current CpG/(G+C) value. Fig.4(D)
is yet another way to look at the same data. If the mutational rate is the same in regions
with different current (G+C)%, the proportion of G or C bases among those that experience
a de novo mutation will be linearly proportional to the current (G+C)%. Nonlinearity of this
“substituted-base G+C content” in bacterial genomes has been observed (Bohlin et al., 2018).
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The fact that our Fig.4(D) is further away from the diagonal line (see the grey dashed line)
indicates that human genome is not in a base composition equilibrium state as in bacterial
genomes.
The results in Fig.4 may indicate that isochores are maintained by neutral mutational
dynamics if the mutational rate is estimated from the de novo mutational events. However,
there are still two possibilities: (1) the relatively low mutational AT-driving-force observed in
the current high G+C region is supposed to be still low when the G+C content in the same
region is lower in time. We may justify this assumption by a hypothesis that the mutation
rate in this region is perhaps determined by the three-dimensional chromatin structure than
by the G+C content. (2) our high G+C intergenic region might be embedded in high G+C
genic regions which protect the G+C decay by selection force. In that case, the relatively low
AT-driving-force in the intergenic region is not really neutral. The limiting isochore conclusion
may not be reached if we assume that the mutational driving force in the current high G+C
regions becomes stronger with time, due to the lower G+C content in the future. However,
there is no way to prove this with the current data.
Discussion
In this study, we re-visit the topic which was popular in the past, on base composition change
(Duret et al., 2002; Gu and Li, 2006; Alvarez-Valin et al., 2004; Romiguier et al., 2010), but
focus one one species only, the homo sapiens. Towards this, we rely on the mutational events
observed in human only, i.e., the de novo mutation by comparing the genomic sequences be-
tween parents and offspring. A reliable data on both the mutation rate and context-dependence
is clearly important. Previous work calculated this information by comparing the orthologous
regions between human and chimpanzee, considering chimp as ancestral and count any sin-
gle nucleotide change from chimp to human as mutational events (Supplementary text of
(Samocha et al., 2014)). This approach may obtain more counts, but the directionality of
the mutational events can be questioned. The data we use is guaranteed for the mutational
direction (from parents to offspring) which is an important piece of information on context
analysis.
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Rare variants might be another type of data to study mutation rates and context effect
(Chakraborty, 1981; Kimura, 1983; Neel et al., 1986). However, this approach should deal
with sequencing errors and private variant (i.e., variant found only in one person) should be
validated. Also, population specific reference genomes should be available, so that a so-called
rare variant according to the standard reference genome might be not so rare in a particular
population, and multiple mutations on the same site should be corrected. Considering the
importance of estimating the background neutral mutational rate in the assessment of excess
mutation in a particular gene (Samocha et al., 2014), it could be interesting to compare differ-
ent approaches, with the anticipation of further complexity due to factors such as gender and
age (Jonsson et al., 2018), population (Mathieson and Reich, 2017; Narasimhan et al., 2017),
and chromosome regions (Harpak et al., 2016).
Our conclusion that isochore-like structure, i.e., different regions having different G+C
contents, can be maintained in the limiting configuration of the neutral dynamics, has already
been implied in (page 886 of) (International Human Genome Sequencing Consortium, 2001):
“if K is the equilibrium constant . . . then the equilibrium GC content should be 1/(1+K) . . .
(K) varies as a function of local GC content”. Because the currently (G+C)-rich regions have
lower K (equivalent to our [α1(x)/α2(x)] · [(1−x)/x] in Eq.(4) ), they should also have a higher
G+C content in the limiting equilibrium state. However, our conclusion is reached based on
a more realistic three-variable dynamics (Eq.7). We also caution on an assumption required
for reaching this conclusion, i.e. the mutational rate is a chromosome regional property and
may not be a property of G+C content itself. To confirm or reject the assumption, it might be
necessary to follow the temporal base composition dynamics in an intergenic G+C rich region
in the human genome.
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Appendix
A Derivation of the limiting composition based on mutation rate
The master equation or continuous time Markov process for the dynamics of a genomic unit
with multiple (m) states is (superscript T is for transpose):
d~P
dt
= (MT − I)~P (8)
where ~P is the composition array with m elements, and Mm×m = {Mij} = {Pi→j}(i, j =
1 . . .m) is the m × m transition matrix, with Pi→j the unit time probability for state i to
change to state j, and I the m × m identity matrix. The value of m is 4 for nucleotide
bases, 16 for dinucleotides, 20 for amino acids, 64 for codons, and any values in between or
beyond when degenerate/equivalent states of the genomic unit are combined. For example,
if the strand symmetry is considered, m = 2; if A and T are combined into weak and C and
G combined to strong, m = 2; if C or G within dinucleotide CpG is distinguished from not
within, m = 3; and if stop codons are excluded from all codons, m = 21, etc.
Eq.(8) can be derived by examining the source of state-j frequency change at time t + dt
from that at time t:
pj(t+ dt) = pj(t) +
∑
i 6=j
pi(t)Pi→jdt− pj(t)
∑
k 6=j
Pj→kdt
= pj(t) +
∑
i 6=j
pi(t)Pi→jdt− pj(t)(1− Pj→j)dt
= pj(t) +
∑
i
pi(t)Pi→jdt− pj(t)dt (9)
then,
pj(t+ dt)− pj(t)
dt
=
∑
i
pi(t)Pi→j − pj(t)
=
∑
j′
Pj′→i′pj′(t)− pj(t)
=
∑
j′
MTi′jpj′(t)− pj(t) (10)
which is Eq.(8) in the dt→ 0 limit.
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The equilibrium composition is the solution of dP˜/dt = 0 = (MT − I)~P which is an eigen-
value/eigenvector problem. This type of dynamical systems is also called (multi) compart-
mental systems (Jacquez, 1972), and it is known that the only non-negative eigenvalue of
compartmental matrix MT − I is zero (the largest eigenvalue of matrix MT is one) (Jacquez,
1972). In other words, the limiting composition is the (normalized) eigenvector corresponding
to the eigenvalue=1 of the transpose of Markov transition matrix.
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Figure 1: Illustration of the analytic expression of the first element in the limiting array in Eq.(7), which is
proportional to β1. This expression is the sum of three terms: nSpWnSW , nSnSpnSpW , and nSpSnnSnW where
W is weak base (A or T), Sn is strong base (C or G) not involved in a CpG context, and Sp for S in a CpG
context. These three terms can be represented by the subplots (1), (2) and (3) .
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Figure 2: Distribution of various statistics of the de novomutations according to nine different categories: stop-
gain/loss, missense, splice donor/acceptor, synonymous, 3’/5’-UTR, non-coding-exon, intron, up/downstream-
gene, intergenic. (1) CADD; (2) percentage of non-repetitive sequence in the 2kb window centered at the
mutation site ; (3) (G+C)-content in the 2kb window; (4) (G+C)-content in the 20kb window; (5) CpG/(G+C)
in the 2kb window; (6) CpG/(G+C) in the 20kb window.
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Figure 3: Each point is an intergenic region in the human genome (regions longer than 100kb are split into
multiple 100kb windows), where x is G+C content, y is the CpG/(G+C) proportion. Larger windows/regions
(> 80kb) are represented by circles. The x=G+C is partitioned into 6 ranges, where the blue dots represent
the bin average. The chromosome-level averages are indicated by red letters.
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Figure 4: Evidence that current isochore structure might be maintained in the equilibrium configuration in
neutral dynamics. Each bin represents a collection of de novo events in intergenic regions with specific 2kb
window G+C content. The first five G+C bin points contain 6000-7000 mutational events each, whereas the
last 3 high G+C bin points only 2000-3000 mutational events each. (A) pS→W
pW→S
(Eq.(3)) or α1(x)
α2(x)
· 1−x
x
(Eq.(4))
as a function of current 2kb G+C content; (B) limiting G+C by Eq.(4) or Eq.(7) as a function of current 2kb
G+C content; (C) limiting CpG/(G+C) by Eq.(7) as a function of current 2kb CpG/(G+C); (D) proportion
of G+C among bases which have experienced de novo mutation. The grey lines in (B), (C), (D) represent
slope=1 diagonal lines.
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type n n(WS) n(WSp) n(SW) n(SSp) n(SpW) n(SpS) α1 α2 β1 β2 β3
intron 58824 14100 5926 18051 1108 11646 523 0.597 0.403 0.434 0.326 0.241
intergenic 40375 9813 4018 13277 732 6705 303 0.591 0.409 0.423 0.302 0.274
missense 3235 493 272 875 70 1083 59 0.719 0.281 0.553 0.298 0.150
stream 4832 1041 513 1505 123 991 44 0.616 0.384 0.449 0.294 0.257
synonymous 1336 167 112 431 24 508 10 0.771 0.229 0.623 0.232 0.145
UTR 1514 359 136 464 34 307 32 0.609 0.391 0.449 0.337 0.214
non-coding 634 98 68 169 19 171 16 0.672 0.328 0.506 0.282 0.213
stop 149 3 1 61 0 66 0 0.969 0.031 0.940 0.046 0.006
splice 81 4 16 42 0 1 0 0.683 0.317 0.058 0.006 0.936
Table 1: Statistics of the de novo mutational events used: type: 9 functional groups are used by simplifying
the original 18 groups; n: number of mutational events; n(WS): number of de novo mutation from W (A
or T) to S (G or C) bases outside a CpG-containing triplet; n(WSp): number of de novo mutation from W
to S bases within a CpG-containing triplet ; n(SW ): number of de novo mutation from S (non-CpG) to W
bases; n(SSp): number of de novo mutation from S (non-CpG) to S (CpG containing) bases; α1, α2: defined
in Eq.(3), satisfying α1 + α2 = 1; β1, β2, β3: defined in Eq.(7), satisfying β1 + β2 + β3 = 1.
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(i) de novo mutation in intergenic regions
G+C range n n(WS) n(WSp) n(SW) n(SSp) n(SpW) n(SpS) α1 α2 β1 β2 β3
0.1 - 0.35 6449 2008 558 2075 78 698 27 0.519 0.481 0.355 0.335 0.310
0.35- 0.38 7288 2045 724 2361 109 1011 31 0.549 0.451 0.382 0.320 0.299
0.38- 0.40 6890 1775 639 2383 124 905 37 0.577 0.423 0.401 0.289 0.310
0.40 -0.43 6125 1365 620 2039 114 1092 48 0.612 0.388 0.443 0.287 0.270
0.43 -0.47 6315 1285 645 2193 128 1260 45 0.641 0.359 0.473 0.267 0.260
0.47 - 0.76 7308 1335 832 2226 179 1739 115 0.647 0.353 0.480 0.278 0.242
0.47 - 0.5 3136 610 330 985 65 696 38 0.641 0.359 0.476 0.285 0.239
0.5 - 0.54 1964 373 230 602 49 455 28 0.637 0.363 0.469 0.279 0.252
0.54 - 0.76 2208 352 272 639 65 588 49 0.663 0.337 0.496 0.265 0.239
(ii) equilibrium (G+C)% andf CpG%
G+C range (G+C)% CpG%/(G+C)% eq(G+C) by Eq.(4) eq(G+C) by Eq.(7) eq CpG/(G+C) by Eq.(7)
0.1 - 0.35 0.343 0.0309 0.326 0.329 0.0286
0.35- 0.38 0.365 0.0320 0.321 0.325 0.0300
0.38- 0.40 0.389 0.0355 0.319 0.315 0.0380
0.40- 0.43 0.413 0.0418 0.309 0.313 0.0394
0.43- 0.47 0.447 0.0518 0.311 0.313 0.0506
0.47- 0.76 0.496 0.0667 0.350 0.361 0.0586
0.47 - 0.5 0.482 0.0618 0.343 0.356 0.0524
0.5 - 0.54 0.513 0.0721 0.376 0.384 0.0653
0.54 - 0.76 0.560 0.0932 0.393 0.403 0.0849
Table 2: Statistics of intergenic de novo mutations partitioned into their 2kb window G+C content range (6
bins for rough equal number partition, and last bin further split into three bins): (i) see the caption of Table 1;
(ii) predicted limiting equilibrium by current G+C content using Eq.(4), or by both current G+C and current
CpG/(G+C) using Eq.(7).
